Federated Hermes Inc. acquired a new stake in shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 400,000 shares of the company's stock, valued at approximately $9,968,000. Federated Hermes Inc. owned approximately 0.78% of Kestra Medical Technologies at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Brown Advisory Inc. acquired a new position in shares of Kestra Medical Technologies in the 1st quarter valued at $13,716,000. TD Asset Management Inc acquired a new position in shares of Kestra Medical Technologies in the 1st quarter valued at $2,306,000. Jennison Associates LLC acquired a new position in Kestra Medical Technologies in the 1st quarter valued at $1,869,000. Finally, Caas Capital Management LP purchased a new stake in shares of Kestra Medical Technologies during the 1st quarter worth $1,470,000.
Analyst Ratings Changes
A number of analysts recently issued reports on KMTS shares. Wells Fargo & Company dropped their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th. The Goldman Sachs Group lowered their price target on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.33.
View Our Latest Report on Kestra Medical Technologies
Kestra Medical Technologies Trading Down 7.6%
NASDAQ KMTS traded down $1.21 on Wednesday, reaching $14.65. The company had a trading volume of 107,231 shares, compared to its average volume of 282,937. Kestra Medical Technologies, Ltd. has a 52 week low of $13.25 and a 52 week high of $26.15. The company has a 50 day moving average of $17.25. The company has a current ratio of 6.72, a quick ratio of 6.72 and a debt-to-equity ratio of 0.20.
About Kestra Medical Technologies
(
Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
See Also
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access